Koers True Leaf Medicine International Ltd Canadian Securities Exchange
Aandelen
CA89785C1077
Farmaceutische producten
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 4,2 mln. 3,07 mln. 2,85 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -6 mln. -4,39 mln. -4,07 mln. | Nettowinst (verlies) 2022 | -2 mln. -1,46 mln. -1,36 mln. | EV/omzet 2021 | - |
Nettoschuld 2021 | 4,22 mln. 3,08 mln. 2,86 mln. | Nettoschuld 2022 | 5,91 mln. 4,32 mln. 4,01 mln. | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-1,36
x | K/w-verhouding 2022 |
-1,66
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 88,37% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Darcy E. Bomford
FOU | Founder | - | 01-01-13 |
Jennifer Pace
DFI | Director of Finance/CFO | - | 01-04-20 |
Rik Klingle-Watt
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mike Harcourt
CHM | Chairman | - | 09-06-14 |
Jennifer Pace
DFI | Director of Finance/CFO | - | 01-04-20 |
Darcy E. Bomford
FOU | Founder | - | 01-01-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,25% | 6,3 mld. | |
-15,08% | 4,44 mld. | |
-6,70% | 3,27 mld. | |
+5,47% | 3,16 mld. | |
+0,76% | 2,58 mld. | |
+47,75% | 1,96 mld. | |
-5,08% | 1,73 mld. | |
+2,05% | 1,68 mld. | |
-7,08% | 1,63 mld. |